| Inflammation: A bridge between diabetes and COVID-19, and possible management with sitagliptin N Mozafari, S Azadi, S Mehdi-Alamdarlou, H Ashrafi, A Azadi Medical hypotheses 143, 110111, 2020 | 66 | 2020 |
| Mathematical modeling of drug release from swellable polymeric nanoparticles S Azadi, H Ashrafi, A Azadi Journal of Applied Pharmaceutical Science 7, 125-133, 2017 | 63 | 2017 |
| A novel approach to the application of hexagonal mesoporous silica in solid-phase extraction of drugs F Farjadian, S Azadi, S Mohammadi-Samani, H Ashrafi, A Azadi Heliyon 4 (11), 2018 | 17 | 2018 |
| Simvastatin-chitosan-citicoline conjugates nanoparticles as the co-delivery system in Alzheimer susceptible patients N Mozafari, F Farjadian, SM Samani, S Azadi, A Azadi International journal of biological macromolecules 156, 1396-1407, 2020 | 15 | 2020 |
| A hopeful prospect of riociguat as a soluble guanylate cyclase stimulator for management of pressure ulcers S Azadi, H Ashrafi, A Azadi Current Drug Discovery Technologies 15 (1), 20-23, 2018 | 6 | 2018 |
| Genetic polymorphisms of glucocorticoid receptor and their association with new-onset diabetes mellitus in kidney transplant recipients S Azadi, N Azarpira, J Roozbeh, S Ezzatzadegan-Jahromi, ... Gene 856, 147138, 2023 | 3 | 2023 |
| Concurrent analysis of Simvastatin and citicoline using a Reversed-phase High Performance Liquid Chromatography-Ultra Violet Method N Mozafari, S Azadi, S Mohammadi Samani, F Farjadian, A Azadi Trends in Pharmaceutical Sciences 5 (1), 41-46, 2019 | 2 | 2019 |
| A reversed-phase high performance liquid chromatography approach for analysis of 5-Fluorouracil S Azadi, A Azadi, H Ashrafi, S Mohammadi-Samani Trends in Pharmaceutical Sciences 3 (1), 49-54, 2017 | 2 | 2017 |
| Drug-related Problems in Solid-Organ Transplant Recipients Hospitalized for COVID-19: An Experience of a Referral Tertiary Center in Iran S Azadi, F Shahabinezhad, M Shafiekhani Iranian Journal of Medical Sciences 47 (6), 577, 2022 | 1 | 2022 |
| Evaluation of the Factors Associated with Prescribed and Non-Prescribed Medicine: A Population-Based Study M Eskandari, AH Alizadeh Bahmani, M Hoorang, M Zare, S Afifi, ... Current drug safety 18 (4), 528-533, 2023 | | 2023 |
| Pharmacokinetic and Pharmacodynamic Considerations of Novel Antibiotic Agents for Pediatric Infections: A Narrative Review M Shafiekhani, SA Fatemi, P Hosseini, F Marhemati, S Mohammadi, ... Surgical Infections 24 (8), 703-715, 2023 | | 2023 |
| Drug utilization evaluation of Rivaroxaban in both inpatient and outpatient settings: Using standard guidelines A Vazin, S Azadi, A Jalali, I Karimzadeh, A Borhani-Haghighi, A Safari, ... Trends in Pharmaceutical Sciences 8 (4), 253-262, 2022 | | 2022 |
| P16. 24: Drug-Related Problems Among Solid Organ Transplant Recipients Hospitalized for COVID-19: An Experience of A Referral Tertiary Center in Iran S Azadi, F Shahabinezhad, M Shafiekhani Transplantation 106 (9S), S737-S738, 2022 | | 2022 |
| Pain management in hospitalized patients with long term opioid use L Mahmoudi, S Azadi Trends in Pharmaceutical Sciences 5 (4), 177-184, 2019 | | 2019 |
| Chitosan Dextran Microparticles as the Potential Carrier for Colon Specific Delivery of 5-Fluorouracil S Azadi, A Azadi, H Ashrafi, S Mohammadi-Samani International Pharmacy Acta 1 (1), 76-77, 0 | | |
Amir AzadiAssociate Professor of Pharmaceutics, Shiraz University of Medical Sciences在 sums.ac.ir 的电子邮件经过验证
